Surov et al., 2015 - Google Patents

Procoagulant impact of the plasmapheresis procedure on coagulation state of collected plasma

Surov et al., 2015

View HTML
Document ID
9416586609981118105
Author
Surov S
Ovsepyan R
Vysochin I
Kobzeva E
Khvatov V
Panteleev M
Vuimo T
Publication year
Publication venue
Blood Transfusion

External Links

Snippet

Plasmapheresis is a group of extracorporeal techniques that involve removal of whole blood, separation of plasma from cellular elements and partial return of blood components (at least the red blood cells) into the circulation. It is widely used for therapy and plasma …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4905—Determining clotting time of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature

Similar Documents

Publication Publication Date Title
Whiting et al. TEG and ROTEM: technology and clinical applications
Lacroix et al. Impact of pre‐analytical parameters on the measurement of circulating microparticles: towards standardization of protocol
Artang et al. Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers
Lippi et al. Quality and reliability of routine coagulation testing: can we trust that sample?
Carr Development of platelet contractile force as a research and clinical measure of platelet function
Abdelfattah et al. Thromboelastography and rotational thromboelastometry use in trauma
Dias et al. New-generation thromboelastography: comprehensive evaluation of citrated and heparinized blood sample storage effect on clot-forming variables
Konstantinidi et al. Clinical application of thromboelastography/thromboelastometry (TEG/TEM) in the neonatal population: a narrative review
Herring et al. Diagnostic approach to small animal bleeding disorders
Lebreton et al. Thrombin generation and cirrhosis: state of the art and perspectives
Tripodi et al. Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma
US20160032355A1 (en) Detection and Classification of an Anticoagulant Using A Clotting Assay
Dashkevich et al. Effect of pre-analytical conditions on the thrombodynamics assay
Glas et al. Sample transport by pneumatic tube system alters results of multiple electrode aggregometry but not rotational thromboelastometry
McMichael et al. In-vitro hypocoagulability on whole blood thromboelastometry associated with in-vivo expansion of red cell mass in an equine model
Rimsans et al. Overview and practical application of coagulation assays in managing anticoagulation with direct oral anticoagulants (DOACs)
Fritsma et al. Whole blood platelet aggregometry
Funk Sample integrity and preanalytical variables
Bolliger et al. Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement
Karapetian Reptilase time (RT)
Bianchi et al. Use of coagulation point-of-care tests in the management of anticoagulation and bleeding in pediatric cardiac surgery: a systematic review
Owen et al. Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism
Dargaud et al. Thrombin generation testing in haemophilia comprehensive care centres
Lancé et al. The effects of pneumatic tube system transport on ROTEM analysis and contact activation assessed by thrombin generation test
Surov et al. Procoagulant impact of the plasmapheresis procedure on coagulation state of collected plasma